Fresenius Medical Care AG (ETR: FME)
Germany
· Delayed Price · Currency is EUR 43.88
-0.02 (-0.05%)
Dec 20, 2024, 5:35 PM CET
Fresenius Medical Care AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 19,239 | 19,454 | 19,398 | 17,619 | 17,859 | 17,477 | Upgrade
|
| Revenue Growth (YoY) | -1.15% | 0.29% | 10.10% | -1.35% | 2.19% | 5.62% | Upgrade
|
| Cost of Revenue | 14,403 | 14,529 | 14,504 | 12,846 | 12,322 | 12,081 | Upgrade
|
| Gross Profit | 4,836 | 4,925 | 4,894 | 4,773 | 5,537 | 5,396 | Upgrade
|
| Selling, General & Admin | 3,148 | 3,196 | 3,170 | 2,773 | 2,966 | 2,944 | Upgrade
|
| Research & Development | 199.42 | 231.97 | 228.62 | 220.78 | 193.77 | 168.03 | Upgrade
|
| Other Operating Expenses | -138.09 | -26.86 | -43.25 | -124.41 | - | - | Upgrade
|
| Operating Expenses | 3,210 | 3,401 | 3,356 | 2,869 | 3,160 | 3,112 | Upgrade
|
| Operating Income | 1,626 | 1,524 | 1,538 | 1,904 | 2,378 | 2,284 | Upgrade
|
| Interest Expense | -417.49 | -424.64 | -360.14 | -353.6 | -409.98 | -491.06 | Upgrade
|
| Interest & Investment Income | 77.21 | 88.22 | 67.66 | 73.17 | 41.96 | 61.62 | Upgrade
|
| Earnings From Equity Investments | 126.1 | 121.79 | 66.56 | 92.18 | 94.52 | 73.68 | Upgrade
|
| Currency Exchange Gain (Loss) | -38.62 | -35.5 | -36.83 | -9.9 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 1,373 | 1,273 | 1,275 | 1,706 | 2,104 | 1,928 | Upgrade
|
| Merger & Restructuring Charges | -240.76 | -259.92 | -147.95 | -37.55 | - | -91.69 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -193.98 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 77.51 | 14.67 | 44.85 | -87.63 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 10.78 | 4.84 | 47.17 | -8.63 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -3.25 | -37.52 | Upgrade
|
| Other Unusual Items | - | - | - | - | 29.41 | 41.54 | Upgrade
|
| Pretax Income | 1,221 | 1,033 | 1,219 | 1,572 | 1,936 | 1,840 | Upgrade
|
| Income Tax Expense | 341.52 | 300.56 | 324.95 | 352.83 | 500.56 | 401.61 | Upgrade
|
| Earnings From Continuing Operations | 879.35 | 732.46 | 894.33 | 1,219 | 1,436 | 1,439 | Upgrade
|
| Minority Interest in Earnings | -220.41 | -233.46 | -220.92 | -249.72 | -271.46 | -238.88 | Upgrade
|
| Net Income | 658.94 | 499 | 673.41 | 969.31 | 1,164 | 1,200 | Upgrade
|
| Net Income to Common | 658.94 | 499 | 673.41 | 969.31 | 1,164 | 1,200 | Upgrade
|
| Net Income Growth | 46.47% | -25.90% | -30.53% | -16.75% | -2.94% | -39.47% | Upgrade
|
| Shares Outstanding (Basic) | 293 | 293 | 293 | 293 | 294 | 303 | Upgrade
|
| Shares Outstanding (Diluted) | 293 | 293 | 293 | 293 | 294 | 303 | Upgrade
|
| Shares Change (YoY) | -0.00% | 0.06% | 0.06% | -0.41% | -2.80% | -1.46% | Upgrade
|
| EPS (Basic) | 2.25 | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | Upgrade
|
| EPS (Diluted) | 2.25 | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | Upgrade
|
| EPS Growth | 46.47% | -25.97% | -30.60% | -16.44% | -0.01% | -38.60% | Upgrade
|
| Free Cash Flow | 1,565 | 1,944 | 1,443 | 1,635 | 3,181 | 1,442 | Upgrade
|
| Free Cash Flow Per Share | 5.33 | 6.63 | 4.92 | 5.58 | 10.81 | 4.76 | Upgrade
|
| Dividend Per Share | 1.190 | 1.190 | 1.120 | 1.350 | 1.340 | 1.200 | Upgrade
|
| Dividend Growth | 6.25% | 6.25% | -17.04% | 0.75% | 11.67% | 2.56% | Upgrade
|
| Gross Margin | 25.14% | 25.32% | 25.23% | 27.09% | 31.01% | 30.87% | Upgrade
|
| Operating Margin | 8.45% | 7.83% | 7.93% | 10.81% | 13.31% | 13.07% | Upgrade
|
| Profit Margin | 3.43% | 2.57% | 3.47% | 5.50% | 6.52% | 6.86% | Upgrade
|
| Free Cash Flow Margin | 8.13% | 9.99% | 7.44% | 9.28% | 17.81% | 8.25% | Upgrade
|
| EBITDA | 2,416 | 2,379 | 2,450 | 2,799 | 3,261 | 3,137 | Upgrade
|
| EBITDA Margin | 12.56% | 12.23% | 12.63% | 15.88% | 18.26% | 17.95% | Upgrade
|
| D&A For EBITDA | 789.62 | 855.58 | 911.81 | 894.89 | 882.87 | 853.13 | Upgrade
|
| EBIT | 1,626 | 1,524 | 1,538 | 1,904 | 2,378 | 2,284 | Upgrade
|
| EBIT Margin | 8.45% | 7.83% | 7.93% | 10.81% | 13.31% | 13.07% | Upgrade
|
| Effective Tax Rate | 27.97% | 29.10% | 26.65% | 22.45% | 25.85% | 21.83% | Upgrade
|
| Revenue as Reported | 19,239 | 19,454 | 19,398 | 17,619 | 17,859 | 17,477 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.